V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16616860 | 330003277 | EOF | 25 | null | 1 | null | ETOPOSIDE | 330012524 | 330001704 | 330003277 |
| 16616861 | 330003277 | EE813 | 200 | null | 1 | null | CYCLOPHOSPHAMIDE | 330012524 | 330001704 | 330003277 |
| 16616862 | 330003278 | EJL | 1.4 | X724 | 2 | 2017-09-24 | RETINOIC ACID | 330012529 | 330001705 | 330003278 |
| 16616863 | 330003278 | ECL02 | 38 | X721 | 2 | 2017-09-24 | MERCAPTOPURINE | 330012529 | 330001705 | 330003278 |
| 16616864 | 330003278 | ED301 | 3280 | null | 2 | 2017-09-24 | ETOPOSIDE | 330012529 | 330001705 | 330003278 |
| 16616865 | 330003278 | ED301 | 170 | X721 | 1 | 2017-09-24 | IFOSFAMIDE | 330012529 | 330001705 | 330003278 |
| 16616866 | 330003278 | EUDJC | 110 | X724 | null | 2017-09-24 | CYCLOPHOSPHAMIDE | 330012529 | 330001705 | 330003278 |
| 16616867 | 330003279 | EK1EN | 33 | X731 | 1 | 2014-07-09 | CARBOPLATIN | 330012532 | 330001706 | 330003279 |
| 16616868 | 330003279 | EC4 | 50 | X724 | null | 2014-07-10 | CISPLATIN | 330012532 | 330001706 | 330003279 |
| 16616869 | 330003279 | EON | 0 | X721 | 1 | 2014-07-11 | NOT CHEMO | 330012532 | 330001706 | 330003279 |
| 16616870 | 330003281 | ea541 | 6.6 | null | 1 | 2013-03-19 | ETOPOSIDE | 330012534 | 330001707 | 330003281 |
| 16616871 | 330003281 | EK1EN | 3040 | null | 1 | 2013-03-20 | CYTARABINE | 330012534 | 330001707 | 330003281 |
| 16616872 | 330003281 | EAF01 | 44 | null | 1 | 2013-03-20 | ETOPOSIDE | 330012534 | 330001707 | 330003281 |
| 16616873 | 330003281 | ED301 | 100 | X721 | 1 | 2013-03-20 | CARBOPLATIN | 330012534 | 330001707 | 330003281 |
| 16616874 | 330003282 | EE801 | 50 | null | 1 | 2015-10-01 | ETOPOSIDE | 330012535 | 330001708 | 330003282 |
| 16616875 | 330003282 | EE813 | 70 | null | 1 | 2015-10-01 | GEMTUZUMAB OZOGAMYCIN | 330012535 | 330001708 | 330003282 |
| 16616876 | 330003283 | EUDJC | 60 | X724 | 1 | null | ETOPOSIDE | 330012536 | 330006914 | 330003283 |
| 16616877 | 330003284 | EE813 | 1 | X729 | 1 | 2015-04-13 | ETOPOSIDE | 330012539 | 330001709 | 330003284 |
| 16616878 | 330003284 | EK1EN | 70 | null | 2 | 2015-04-13 | NOT CHEMO | 330012539 | 330001709 | 330003284 |
| 16616879 | 330003284 | EW100 | 10 | X724 | 1 | 2015-04-13 | NOT CHEMO | 330012539 | 330001709 | 330003284 |
| 16616880 | 330003285 | EC4 | 145 | X724 | 1 | 2018-02-09 | NOT CHEMO | 330012540 | 330001710 | 330003285 |
| 16616881 | 330003285 | EPH | 210 | N/A | 2 | 2018-02-09 | NOT CHEMO | 330012540 | 330001710 | 330003285 |
| 16616882 | 330003286 | EC4 | 2880 | X721 | 1 | null | STEROID | 330012541 | 330001711 | 330003286 |
| 16616883 | 330003288 | EK1EN | 70 | null | 5 | 2014-01-19 | BORTEZOMIB | 330012543 | 330001712 | 330003288 |
| 16616884 | 330003288 | EQ8 | 11 | null | 1 | 2014-01-19 | VINCRISTINE | 330012543 | 330001712 | 330003288 |
| 16616885 | 330003288 | ED301 | 3900 | X721 | 1 | 2014-01-19 | ETOPOSIDE | 330012543 | 330001712 | 330003288 |
| 16616886 | 330003289 | EPH | 70 | null | 1 | 2016-02-10 | TRIAL | 330012546 | 330001713 | 330003289 |
| 16616887 | 330003289 | EEI00 | 0.58 | null | 1 | 2016-02-10 | CYCLOPHOSPHAMIDE | 330012546 | 330001713 | 330003289 |
| 16616888 | 330003289 | ED301 | 3760 | null | 1 | 2016-02-10 | ETOPOSIDE | 330012546 | 330001713 | 330003289 |
| 16616889 | 330003289 | EXO01 | 70 | X724 | 1 | 2016-02-11 | IFOSFAMIDE | 330012546 | 330001713 | 330003289 |
| 16616890 | 330003289 | ERS12 | 1.38 | X724 | 1 | 2016-02-11 | IFOSFAMIDE | 330012546 | 330001713 | 330003289 |
| 16616891 | 330003289 | EKD50 | 110 | null | 1 | 2016-02-11 | ETOPOSIDE | 330012546 | 330001713 | 330003289 |
| 16616892 | 330003289 | EJR | 3100 | null | 1 | 2016-02-11 | VINCRISTINE | 330012546 | 330001713 | 330003289 |
| 16616893 | 330003289 | EGT | 65 | X721 | 1 | 2016-02-11 | CISPLATIN | 330012546 | 330001713 | 330003289 |
| 16616894 | 330003289 | EX950 | 79 | X721 | 1 | 2016-02-12 | CISPLATIN | 330012546 | 330001713 | 330003289 |
| 16616895 | 330003289 | EGENG | 8 | X724 | 2 | 2016-02-12 | NOT CHEMO | 330012546 | 330001713 | 330003289 |
| 16616896 | 330003291 | EW100 | 28 | X724 | 1 | 2014-10-18 | VINCRISTINE | 330012549 | 330001715 | 330003291 |
| 16616897 | 330003292 | EC4 | 63 | null | 1 | 2015-06-18 | DOXORUBICIN | 330012550 | 330001716 | 330003292 |
| 16616898 | 330003293 | EQ8 | 400 | X722 | 5 | 2016-02-26 | INTERFERON BETA | 330012550 | 330001716 | 330003293 |
| 16616899 | 330003294 | EQ8 | 13 | X729 | 1 | 2017-12-20 | NOT CHEMO | 330012550 | 330001716 | 330003294 |
| 16616900 | 330003295 | EC4 | 200 | X724 | 1 | 2018-01-12 | ETOPOSIDE | 330012554 | 330001717 | 330003295 |
| 16616901 | 330003295 | E0N03 | 40 | X721 | 1 | 2018-01-12 | NOT MATCHED | 330012554 | 330001717 | 330003295 |
| 16616902 | 330003295 | EOA01 | 4200 | null | 2 | 2018-01-12 | ETOPOSIDE | 330012554 | 330001717 | 330003295 |
| 16616903 | 330003295 | EPH | 30 | null | 2 | 2018-01-12 | NOT CHEMO | 330012554 | 330001717 | 330003295 |
| 16616904 | 330003296 | EJU04 | 0.5 | X724 | 1 | 2017-12-22 | PACLITAXEL | 330012557 | 330001718 | 330003296 |
| 16616905 | 330003296 | EJU04 | 0 | X721 | 1 | 2017-12-22 | MESNA | 330012557 | 330001718 | 330003296 |
| 16616906 | 330003298 | ECL02 | 2150 | null | 1 | 2015-09-19 | CYCLOPHOSPHAMIDE | 330012562 | 330001719 | 330003298 |
| 16616907 | 330003298 | EOI | 0 | X724 | 1 | 2015-09-19 | VINCRISTINE | 330012562 | 330001719 | 330003298 |
| 16616908 | 330003298 | EE813 | 12.15 | X724 | 1 | 2015-09-19 | CARBOPLATIN | 330012562 | 330001719 | 330003298 |
| 16616909 | 330003298 | EUDJC | 50 | null | 1 | 2015-09-19 | CISPLATIN | 330012562 | 330001719 | 330003298 |